Important Caveats About the Research Several important limitations should be acknowledged when reviewing the EpitalON literature: The majority of published studies originate from Khavinson's research group or closely affiliated laboratories Independent replication outside Russia has been limited, though the 2025 Biogerontology study represents a notable exception Human clinical data remains sparse, consisting mainly of small studies from one research group Most research has used injectable EpitalON, not oral formulations The peptide is not approved as a medicine in the UK, EU, or US How EpitalON Capsules Are Typically Taken Research Protocol Context The research literature commonly references cycles of 10-20 days at 5-10mg daily, repeated periodically (such as once or twice yearly)
The cellular context of T cell signaling
Telomere & Cellular Aging Support Epithalon's research interest in telomerase activity makes it one of the more longevity-focused peptides in the broader peptide therapy landscape
Glutathione may help manage oxidative stress, support detoxification, and promote overall cellular health, potentially benefiting both the mother and the developing fetus
These perturbations not only facilitate pathogen survival and replication but also shape disease severity and host outcomes, a cross-pathogen comparison that is summarized in Table 1
